Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001623613-15-000029
Filing Date
2015-08-06
Accepted
2015-08-06 17:23:03
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q myl10q_20150630xdoc.htm 10-Q 3127711
2 EXHIBIT 10.1 myl_ex101x20150630-10q.htm EX-10.1 52865
3 EXHIBIT 31.1 myl_ex311x20150630-10q.htm EX-31.1 9268
4 EXHIBIT 31.2 myl_ex312x20150630-10q.htm EX-31.2 9425
5 EXHIBIT 32 myl_ex32x20150630-10q.htm EX-32 9068
  Complete submission text file 0001623613-15-000029.txt   20223485

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT myl-20150630.xml EX-101.INS 6349646
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT myl-20150630.xsd EX-101.SCH 78164
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT myl-20150630_cal.xml EX-101.CAL 137326
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT myl-20150630_def.xml EX-101.DEF 663542
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT myl-20150630_lab.xml EX-101.LAB 1029977
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT myl-20150630_pre.xml EX-101.PRE 772928
Mailing Address BUILDING 4, TRIDENT PLACE, MOSQUITO WAY HATFIELD, HERTFORDSHIRE X0 AL10 9UL
Business Address BUILDING 4, TRIDENT PLACE, MOSQUITO WAY HATFIELD, HERTFORDSHIRE X0 AL10 9UL 44 0 1707 853 000
Mylan N.V. (Filer) CIK: 0001623613 (see all company filings)

EIN.: 981189497 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-199861 | Film No.: 151034263
SIC: 2834 Pharmaceutical Preparations